Physician profile
Aytek Oto
NPI 1528142866
$13,106.48
in general payments reported to CMS, 2019-2025
9 companies · $2,238 in 2025
The $2,238 reported for 2025 was more than what 91% of Diagnostic Radiology providers received nationally (typical 2025 total: $112).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $971 · 2022: $193 · 2023: $1,819 · 2024: $7,885 · 2025: $2,238.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $7,552 · Consulting Fee: $2,425 · Food and Beverage: $1,966.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $7,551.69 |
| Consulting Fee | $2,425.00 |
| Food and Beverage | $1,965.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Profound Medical Corp. | $8,076.17 | 2022-2025 | Tulsa-Pro |
| Novartis Pharmaceuticals Corporation | $1,675.00 | 2023 | |
| Guerbet LLC | $1,645.90 | 2024 | Elucirem |
| Ge Healthcare | $1,171.08 | 2019-2024 | |
| Astellas Pharma US INC | $145.57 | 2025 | Xtandi |
| Siemens Medical Solutions USA, INC. | $122.84 | 2025 | |
| Bracco Diagnostics INC. | $105.03 | 2019 | |
| Philips North America LLC | $94.89 | 2019-2022 | |
| Aidoc Medical LTD | $70.00 | 2024 | Briefcase |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aytek Oto listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.